MOUSTAFA ELDICK: Open Payments
NPI 1962592907 · CRESCENT CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$569 in 34 payments from 10 companies in 2025. Trend: 2023 $907 · 2024 $614 · 2025 $569
Food & beverage: $569
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 15 | $198 |
| ABBVIE INC. | 4 | $73 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $64 |
| Novo Nordisk Inc | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| Exact Sciences Corporation | 3 | $47 |
| Lilly USA, LLC | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Amgen Inc. | 1 | $16 |
Products named: TRELEGY ELLIPTA, JOURNAVX, CAPLYTA, QULIPTA, Ozempic, VRAYLAR, Cologuard Collection Kit, Wegovy.
Industry payments across FL — which companies pay providers there.
